[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617268":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":26,"locations":31,"responsibleParty":57,"collaborators":26,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":26,"enrollmentInfo":69,"targetDuration":26,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":26,"overallStatus":34,"whyStopped":26,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Università degli Studi di Brescia","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Real iTBS - Real iTBS","EXPERIMENTAL","10 sessions of theta burst stimulation (5 days\u002Fweek for 2 weeks) followed by an open-label 10 sessions of theta burst stimulation (5 days\u002Fweek for 2 weeks)",[13],"Device: Theta burst stimulation",{"label":15,"type":16,"description":17,"interventionNames":18},"Sham iTBS - Real iTBS","SHAM_COMPARATOR","10 sessions of sham stimulation (5 days\u002Fweek for 2 weeks) followed by an open-label 10 sessions of theta burst stimulation (5 days\u002Fweek for 2 weeks)",[13,19],"Device: Sham Theta burst stimulation",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","Theta burst stimulation","10 sessions (5 days\u002Fweek for 2 weeks) of 20 trains of 10 bursts, each containing 3 pulses at 50 Hz, applied at a frequency of 5 Hz (total pulses: 600, total duration: approx. 3 minutes); this protocol will be repeated twice within each single session.",[9,15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"Sham Theta burst stimulation","10 sessions (5 days\u002Fweek for 2 weeks) of sham theta burst stimulation.The device providing Theta Burst Stimulation can be placed in the same position and turned on, creating a similar experience for the participant, without providing any neural stimulation.",[15],[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":36,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"IRCCS Istituto Centro San Giovanni Di Dio - Fatebenefratelli Brescia","RECRUITING","Brescia","Italy","25125","IT",{"type":40,"coordinates":41},"Point",[42,43],10.21472,45.53558,{"lat":43,"lon":42},[46,51,55],{"name":47,"role":48,"phone":49,"phoneExt":26,"email":50},"Barbara Borroni, MD","CONTACT","+39 03035358","bborroni@fatebenefratelli.eu",{"name":52,"role":48,"phone":53,"phoneExt":26,"email":54},"Monica Almici, MS","+39 03035360","sct.irccs@fatebenefratelli.eu",{"name":47,"role":56,"phone":26,"phoneExt":26,"email":26},"PRINCIPAL_INVESTIGATOR",{"type":56,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"Barbara Borroni","Professor","100617268","repetitive-transcranial-magnetic-stimulation-in-frontotemporal-lobar-degeneration-100617268",false,"NCT07316413","Repetitive Transcranial Magnetic Stimulation in Frontotemporal Lobar Degeneration","FTLD_rTMS","Inclusion Criteria:\n\n* diagnosis of FTLD (bvFTD, avPPA, svPPA, CBS, or PSP)\n* global CDR plus NACC FTLD ≤ 1\n\nExclusion Criteria:\n\n* presence of cerebrovascular disease, hydrocephalus, intracranial masses identified by MRI, history of head trauma, serious medical conditions unrelated to FTLD, history of epilepsy, and presence of electronic (e.g., pacemaker) or metallic implants in the head.","ALL","18 Years",{"count":70,"type":71},120,"ESTIMATED","INTERVENTIONAL",[74],"NA","The aim of the study is to evaluate the safety, feasibility, clinical and biological efficacy, and predictors of efficacy of an intervention consisting of repetitive transcranial magnetic stimulation (rTMS) in patients with frontotemporal dementia (FTLD) or in asymptomatic persons at risk of FTLD (i.e., persons familiar with FTLD patients).\n\nrTMS is a non-invasive brain stimulation technique, and has demonstrated the ability to modulate neuronal activity by applying high-frequency magnetic fields to the surface of the skull. rTMS offers a potentially effective means to influence neural networks involved in the pathogenesis of neurodegenerative diseases, with benefits that could extend beyond symptomatic relief. Its safety has been widely documented in a variety of clinical conditions, making it an ideal candidate for application in neurodegenerative diseases.\n\nIn the present study, participants will undergo the following procedures: (i) clinical and neuropsychological assessment, (ii) TMS, and (iii) blood sampling. The occurrence of adverse events will be monitored throughout the duration of the study.\n\nThe study is structured in two phases. In the first phase, double-blind, randomised and placebo-controlled, participants will be randomised into two groups: group 1, participants will receive real rTMS for 2 weeks; and group 2, placebo rTMS for 2 weeks. In the second, open-label phase, after 10 weeks, both group 1 and group 2 participants will receive real rTMS for 2 weeks. Each participant will receive a total of 4 weeks of intervention (4 weeks of real stimulation in group 1, or 2 weeks of real stimulation and 2 weeks of placebo stimulation in group 2), with 5 sessions per week (Monday to Friday) lasting approximately 30 minutes each.\n\nVisits will take place at the beginning of the study (T00) and after 2 weeks (T02, end of the first phase), 12 weeks (T12, beginning of the second phase), 14 weeks (T14, end of the second phase), 24 weeks (T24, follow-up). During each visit, participants underwent the following procedures: (i) clinical and neuropsychological assessment, (ii) blood sampling, and (iii) TMS. Specific biomarker analyses will be performed on the blood samples to study the pathophysiological mechanisms of the disease and the effect of the experimental intervention.",[77,78,79,80,81,82,83,84],"FTLD","FTD","bvFTD","PPA","PSP","Cortical Basal Syndrome (CBS)","rTMS","Theta Burst Stimulation","2025-12-18",{"date":87,"type":88},"2026-01-05","ACTUAL",{"date":90,"type":88},"2025-02-13",{"date":92,"type":71},"2029-02-01",{"name":5,"class":6},1]